# Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

> **NCT04477681** · — · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 1150 (estimated)

## Conditions studied

- Pediatric Cancer

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04477681
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-04-09
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 1150 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477681, "Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04477681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*